Apo6619
Apo6619 is an iron chelator with antibacterial activity that inhibits a variety of common bacteria associated with hospital-acquired infections. Apo6619 inhibits the growth of relevant bacterial strains in cation-adjusted Mueller-Hinton broth and RPMI 1640 tissue culture medium. Apo6619 can be used in antibacterial research on hospital-acquired infection-related bacteria based on the iron chelation mechanism.
For research use only. We do not sell to patients.
- CAS No.: 887774-94-9
- Formula: C11H14N2O3
- Molecular Weight:222.24
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
Apo6619 inhibits the growth of A. baumannii ATCC 17978 and 19606 in CAMHB, with an MIC of 256 μg/mL for both strains; it also exhibits an MIC of 256 μg/mL against E. coli ATCC 35718 and 43888[1].
Apo6619 exhibits MIC values of > 512 μg/mL against Staphylococcus aureus ATCC 25923, 43300, Pseudomonas aeruginosa PAO1, ATCC 27853, and Klebsiella pneumoniae BAA-2146, 700603 in CAMHB[1].
Apo6619 inhibits the growth of A. baumannii ATCC 17978 and 19606 in RPMI 1640 medium, with MIC values of 64 μg/mL and 128 μg/mL, respectively; it exhibits an MIC of 256 μg/mL against both E. coli ATCC 35718 and 43888[1].
The MIC of Apo6619 against P. aeruginosa PAO1, K. pneumoniae BAA-2146 and 700603 in RPMI 1640 medium is 512 μg/mL, while its MIC against P. aeruginosa ATCC 27853 is > 512 μg/mL[1].
Apo6619 exhibits antibacterial activity in the time-kill assay[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
CAS No. 887774-94-9
-
Molecular Weight 222.24
-
Formula C11H14N2O3
-
SMILES
O=C1C=C(N(C(C(=O)NC)=C1O)C2CC2)C
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
Bacterial live/dead nucleic-acid viability staining
The LIVE/DEAD bacterial viability staining method is based on differential permeability of nucleic-acid-binding fluorescent dyes, most commonly SYTO 9 and propidium iodide (PI), which enables discrimination of bacterial populations with intact versus compromised cytoplasmic membranes. SYTO 9 penetrates both intact and damaged bacterial membranes and binds nucleic acids to produce green fluorescence, whereas propidium iodide penetrates only cells with compromised membranes and fluoresces red while also reducing SYTO 9 signal through competitive binding and fluorescence interactions. The resulting fluorescence pattern is interpreted as a proxy for membrane integrity, which is widely used as an indicator of bacterial viability in microscopy, flow cytometry, and spectroscopic platforms. However, mechanistic studies show that SYTO 9 and PI interactions involve displacement and fluorescence resonance energy transfer effects, which can influence signal interpretation depending on dye ratios a
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- Apo6619
- 887774-94-9
- Apo 6619
- Apo-6619
- Bacterial
- Escherichia coli
- Pseudomonas aeruginosa
- cation-adjusted Mueller-Hinton broth
- nosocomial bacterial infections
- Acinetobacter baumannii
- Gram-negative bacterial strains
- Staphylococcus aureus
- Klebsiella pneumoniae
- RPMI 1640 tissue culture medium
- Inhibitor
- inhibitor
- inhibit